Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Higher Serum Soluble TREM2 as a Potential Indicative Biomarker for Cognitive Impairment in Inadequately Controlled Type 2 Diabetes Without Obesity: The DOR-KyotoJ-1.
Tanaka M, Yamakage H, Muranaka K, Yamada T, Araki R, Ogo A, Matoba Y, Watanabe T, Saito M, Kurita S, Yonezawa K, Tanaka T, Suzuki M, Sawamura M, Matsumoto M, Nishimura M, Kusakabe T, Wada H, Hasegawa K, Kotani K, Noda M, Satoh-Asahara N. Tanaka M, et al. Among authors: saito m. Front Endocrinol (Lausanne). 2022 May 3;13:880148. doi: 10.3389/fendo.2022.880148. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35592778 Free PMC article.
Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese patients with diabetes.
Tanaka M, Yamakage H, Masuda S, Inoue T, Ohue-Kitano R, Araki R, Matoba Y, Saito M, Nagaoka T, Yonezawa K, Tanaka T, Suzuki M, Sawamura M, Nishimura M, Odori S, Wada H, Kotani K, Kusakabe T, Shimatsu A, Hasegawa K, Satoh-Asahara N. Tanaka M, et al. Among authors: saito m. Diabetes Metab. 2019 Jan;45(1):86-89. doi: 10.1016/j.diabet.2017.06.006. Epub 2017 Jul 31. Diabetes Metab. 2019. PMID: 28774784 No abstract available.
Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
Ito R, Yamakage H, Kotani K, Wada H, Otani S, Yonezawa K, Ogo A, Okajima T, Adachi M, Araki R, Yoshida K, Saito M, Nagaoka T, Toyonaga T, Tanaka T, Yamada T, Ota I, Oishi M, Miyanaga F, Shimatsu A, Satoh-Asahara N; Japan Diabetes and Obesity Study (J-DOS) Group. Ito R, et al. Among authors: saito m. Endocr J. 2015;62(2):201-7. doi: 10.1507/endocrj.EJ14-0352. Epub 2014 Nov 14. Endocr J. 2015. PMID: 25399862 Free article.
Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia.
Tagami T, Kimura H, Ohtani S, Tanaka T, Tanaka T, Hata S, Saito M, Miyazaki Y, Araki R, Tanaka M, Yonezawa K, Sawamura M, Ise T, Ogo A, Shimbo T, Shimatsu A, Naruse M; PHPH study group. Tagami T, et al. Among authors: saito m. Endocr J. 2011;58(6):449-57. doi: 10.1507/endocrj.k11e-012. Epub 2011 Apr 20. Endocr J. 2011. PMID: 21505266 Free article.
Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis.
Ishikawa D, Zhang X, Nomura K, Shibuya T, Hojo M, Yamashita M, Koizumi S, Yamazaki F, Iwamoto S, Saito M, Kunigo K, Nakano R, Honma N, Urakawa I, Nagahara A. Ishikawa D, et al. Among authors: saito m. Inflamm Bowel Dis. 2024 May 11:izae080. doi: 10.1093/ibd/izae080. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38733623
8,193 results